To investigate the safety and efficacy of OTL38, a folate-targeted, intraoperative fluorescence agent, in patients undergoing robotic-assisted laparoscopic partial nephrectomy.
Patients with proven or suspected localized renal cell carcinoma at a single academic institution were selected from 2016 to 2018.